NPA Files Citizen’s Petition With FDA on Specific CBD Relief
On Feb. 22, in a Citizen’s Petition to the U.S. Food and Drug Administration (FDA), the Natural Products Association (NPA) [...]
cannabidiol
Innovation Strategies to Deliver CBD Products With Speed and Confidence
It’s a new year, and 2022 has the potential to be remembered as the year when minor cannabinoids achieved major status. [...]
AHPA Updates Proposition 65 Hemp Industry Guidance Following Passage of California AB 45
The American Herbal Products Association (AHPA) has published an update to its Guidance on California Proposition 65 and [...]
California Legalizes CBD in Dietary Supplements, Food and Cosmetics
On Oct. 6, California Governor Gavin Newsom signed AB 45, legalizing cannabidiol (CBD) in dietary supplements, food [...]
Associations Denounce FDA Rejection of NDI Notifications for Hemp Extract Containing CBD
The Council for Responsible Nutrition (CRN) and the Natural Products Association (NPA) have denounced the U.S. Food and Drug [...]
DSM Partners With Cannabinoid Ingredient Manufacturer Mile High Labs
Royal DSM (Heerlen, The Netherlands) has announced it has entered into a broad commercial partnership with industry-leading [...]
Bipartisan Legislation Introduced Would Create Regulatory Pathways for Use of Hemp-derived CBD in Dietary Supplements and Conventional Food
On May 19, Senators Ron Wyden and Jeff Merkley (D-OR) and Senator Rand Paul (R-KY) introduced bipartisan legislation that [...]
FDA Warns Selling of Topical CBD Products Violates FD&C Act
On March 22, the U.S. Food and Drug Administration (FDA) stated that it has issued warning letters to two companies for [...]
CRN: New FDA Announcement on CBD Signals Continued Agency Inaction
In response to a notice issued on Jan. 8, 2021, from the U.S. Food and Drug Administration (FDA), titled, “Better Data [...]
Senate Confirms Hahn as FDA Commissioner
In a 72-18 Senate vote, Stephen Hahn, MD, FASTRO was confirmed as the new head of the U.S. Food and Drug Administration [...]